Patents by Inventor Matthew J. D'Onofrio

Matthew J. D'Onofrio has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of moderate and severe gastroparesis
    Patent number: 12377064
    Abstract: Metoclopramide is administered for the treatment of moderate to severe gastroparesis, in some embodiments, severe gastroparesis.
    Type: Grant
    Filed: October 18, 2022
    Date of Patent: August 5, 2025
    Assignee: EVOKE PHARMA, INC.
    Inventors: Marilyn R. Carlson, Matthew J. D'Onofrio, David A. Gonyer, Wayne Alves
  • NASAL FORMULATIONS OF METOCLOPRAMIDE
    Publication number: 20250228803
    Abstract: Nasal formulations of metoclopramide, which remain stable and/or colorless upon storage over a period of time, are provided. Also provided are methods of treating disorders treatable with metoclopramide, comprising administering the nasal solutions to patients in need thereof.
    Type: Application
    Filed: December 2, 2024
    Publication date: July 17, 2025
    Inventors: Matthew J. D'ONOFRIO, David A. GONYER, Shirish A. SHAH, Stuart J. MADDEN
  • Nasal formulations of metoclopramide
    Patent number: 12194009
    Abstract: Nasal formulations of metoclopramide, which remain stable and/or colorless upon storage over a period of time, are provided. Also provided are methods of treating disorders treatable with metoclopramide, comprising administering the nasal solutions to patients in need thereof.
    Type: Grant
    Filed: July 2, 2021
    Date of Patent: January 14, 2025
    Assignee: Evoke Pharma, Inc.
    Inventors: Matthew J. D'Onofrio, David A. Gonyer, Shirish A. Shah, Stuart J. Madden
  • Nasal formulations of metoclopramide
    Patent number: 12194008
    Abstract: Nasal formulations of metoclopramide, which remain stable and/or colorless upon storage over a period of time, are provided. Also provided are methods of treating disorders treatable with metoclopramide, comprising administering the nasal solutions to patients in need thereof.
    Type: Grant
    Filed: July 2, 2021
    Date of Patent: January 14, 2025
    Assignee: Evoke Pharma, Inc.
    Inventors: Matthew J. D'Onofrio, David A. Gonyer, Shirish A. Shah, Stuart J. Madden
  • Nasal formulations of metoclopramide
    Patent number: 11813231
    Abstract: Nasal formulations of metoclopramide, which remain stable and/or colorless upon storage over a period of time, are provided. Also provided are methods of treating disorders treatable with metoclopramide, comprising administering the nasal solutions to patients in need thereof.
    Type: Grant
    Filed: July 2, 2021
    Date of Patent: November 14, 2023
    Assignee: Evoke Pharma, Inc.
    Inventors: Matthew J. D'Onofrio, David A. Gonyer, Shirish A. Shah, Stuart J. Madden
  • Nasal formulations of metoclopramide
    Patent number: 11628150
    Abstract: Nasal formulations of metoclopramide, which remain stable and/or colorless upon storage over a period of time, are provided. Also provided are methods of treating disorders treatable with metoclopramide, comprising administering the nasal solutions to patients in need thereof.
    Type: Grant
    Filed: November 20, 2020
    Date of Patent: April 18, 2023
    Assignee: Evoke Pharma, Inc.
    Inventors: Matthew J. D'Onofrio, David A. Gonyer, Shirish A. Shah, Stuart J. Madden
  • TREATMENT OF MODERATE AND SEVERE GASTROPARESIS
    Publication number: 20230094778
    Abstract: Metoclopramide is administered for the treatment of moderate to severe gastroparesis, in some embodiments, severe gastroparesis.
    Type: Application
    Filed: October 18, 2022
    Publication date: March 30, 2023
    Inventors: Marilyn R. CARLSON, Matthew J. D'ONOFRIO, David A. GONYER, Wayne ALVES
  • Treatment of moderate and severe gastroparesis
    Patent number: 11517545
    Abstract: Metoclopramide is administered for the treatment of moderate to severe gastroparesis, in some embodiments, severe gastroparesis.
    Type: Grant
    Filed: December 13, 2017
    Date of Patent: December 6, 2022
    Assignee: EVOKE Pharma, Inc.
    Inventors: Marilyn R. Carlson, Matthew J. D'Onofrio, David A. Gonyer, Wayne Alves
  • TREATMENT OF SYMPTOMS ASSOCIATED WITH FEMALE GASTROPARESIS
    Publication number: 20220151960
    Abstract: Nasal formulations of metoclopramide are administered for the treatment of symptoms associated with female gastroparesis. Also provided are methods of treating symptoms of female gastroparesis with nasal metoclopramide.
    Type: Application
    Filed: July 21, 2021
    Publication date: May 19, 2022
    Inventors: Matthew J. D'ONOFRIO, David A. GONYER, Marilyn R. CARLSON
  • NASAL FORMULATIONS OF METOCLOPRAMIDE
    Publication number: 20210338608
    Abstract: Nasal formulations of metoclopramide, which remain stable and/or colorless upon storage over a period of time, are provided. Also provided are methods of treating disorders treatable with metoclopramide, comprising administering the nasal solutions to patients in need thereof.
    Type: Application
    Filed: July 2, 2021
    Publication date: November 4, 2021
    Inventors: Matthew J. D'ONOFRIO, David A. GONYER, Shirish A. SHAH, Stuart J. MADDEN
  • NASAL FORMULATIONS OF METOCLOPRAMIDE
    Publication number: 20210330618
    Abstract: Nasal formulations of metoclopramide, which remain stable and/or colorless upon storage over a period of time, are provided. Also provided are methods of treating disorders treatable with metoclopramide, comprising administering the nasal solutions to patients in need thereof.
    Type: Application
    Filed: July 2, 2021
    Publication date: October 28, 2021
    Inventors: Matthew J. D'ONOFRIO, David A. GONYER, Shirish A. SHAH, Stuart J. MADDEN
  • NASAL FORMULATIONS OF METOCLOPRAMIDE
    Publication number: 20210330619
    Abstract: Nasal formulations of metoclopramide, which remain stable and/or colorless upon storage over a period of time, are provided. Also provided are methods of treating disorders treatable with metoclopramide, comprising administering the nasal solutions to patients in need thereof.
    Type: Application
    Filed: July 2, 2021
    Publication date: October 28, 2021
    Inventors: Matthew J. D'ONOFRIO, David A. GONYER, Shirish A. SHAH, Stuart J. MADDEN
  • Nasal formulations of metoclopramide
    Patent number: 11020361
    Abstract: Nasal formulations of metoclopramide, which remain stable and/or colorless upon storage over a period of time, are provided. Also provided are methods of treating disorders treatable with metoclopramide, comprising administering the nasal solutions to patients in need thereof.
    Type: Grant
    Filed: November 6, 2018
    Date of Patent: June 1, 2021
    Assignee: Evoke Pharma, Inc.
    Inventors: Matthew J. D'Onofrio, David A. Gonyer, Shirish A. Shah, Stuart J. Madden
  • NASAL FORMULATIONS OF METOCLOPRAMIDE
    Publication number: 20210093590
    Abstract: Nasal formulations of metoclopramide, which remain stable and/or colorless upon storage over a period of time, are provided. Also provided are methods of treating disorders treatable with metoclopramide, comprising administering the nasal solutions to patients in need thereof.
    Type: Application
    Filed: November 20, 2020
    Publication date: April 1, 2021
    Inventors: Matthew J. D'ONOFRIO, David A. GONYER, Shirish A. SHAH, Stuart J. MADDEN
  • TREATMENT OF SYMPTOMS ASSOCIATED WITH FEMALE GASTROPARESIS
    Publication number: 20200405666
    Abstract: Nasal formulations of metoclopramide are administered for the treatment of symptoms associated with female gastroparesis. Also provided are methods of treating symptoms of female gastroparesis with nasal metoclopramide.
    Type: Application
    Filed: June 22, 2018
    Publication date: December 31, 2020
    Inventors: Matthew J. D'ONOFRIO, David A. GONYER, Marilyn R. CARLSON
  • METHODS OF INTRANASAL METOCLOPRAMIDE DOSING
    Publication number: 20200276139
    Abstract: The present disclosure relates to methods of intranasal metoclopramide dosing.
    Type: Application
    Filed: September 10, 2018
    Publication date: September 3, 2020
    Inventors: Marilyn R. CARLSON, Wayne ALVES, Matthew J. D'ONOFRIO, David A. GONYER
  • TREATMENT OF SYMPTOMS ASSOCIATED WITH FEMALE GASTROPARESIS
    Publication number: 20190388370
    Abstract: Nasal formulations of metoclopramide are administered for the treatment of symptoms associated with female gastroparesis. Also provided are methods of treating symptoms of female gastroparesis with nasal metoclopramide.
    Type: Application
    Filed: June 22, 2018
    Publication date: December 26, 2019
    Inventors: Matthew J. D'ONOFRIO, David A. GONYER, Marilyn R. CARLSON
  • TREATMENT OF MODERATE AND SEVERE GASTROPARESIS
    Publication number: 20190328686
    Abstract: Metoclopramide is administered for the treatment of moderate to severe gastroparesis, in some embodiments, severe gastroparesis.
    Type: Application
    Filed: December 13, 2017
    Publication date: October 31, 2019
    Inventors: Marilyn R. CARLSON, Matthew J. D'ONOFRIO, David A. GONYER, Wayne ALVES
  • NASAL FORMULATIONS OF METOCLOPRAMIDE
    Publication number: 20190070134
    Abstract: Nasal formulations of metoclopramide, which remain stable and/or colorless upon storage over a period of time, are provided. Also provided are methods of treating disorders treatable with metoclopramide, comprising administering the nasal solutions to patients in need thereof.
    Type: Application
    Filed: November 6, 2018
    Publication date: March 7, 2019
    Inventors: Matthew J. D'ONOFRIO, David A. GONYER, Shirish A. SHAH, Stuart J. MADDEN
  • NASAL FORMULATIONS OF METOCLOPRAMIDE
    Publication number: 20170071885
    Abstract: Nasal formulations of metoclopramide, which remain stable and/or colorless upon storage over a period of time, are provided. Also provided are methods of treating disorders treatable with metoclopramide, comprising administering the nasal solutions to patients in need thereof.
    Type: Application
    Filed: April 15, 2016
    Publication date: March 16, 2017
    Inventors: Matthew J. D'Onofrio, David A. Gonyer, Shirish A. Shah, Stuart J. Madden